Search by Drug Name or NDC
NDC 00280-4000-02 Alka-Seltzer Original 1000; 325; 1916 mg/1; mg/1; mg/1 Details
Alka-Seltzer Original 1000; 325; 1916 mg/1; mg/1; mg/1
Alka-Seltzer Original is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Bayer HealthCare LLC.. The primary component is ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE.
Product Information
| NDC | 00280-4000 |
|---|---|
| Product ID | 0280-4000_0bb55660-27bb-c2ea-e063-6394a90a3a0e |
| Associated GPIs | 64109902110820 |
| GCN Sequence Number | 059732 |
| GCN Sequence Number Description | aspirin/sod bicarb/citric acid TABLET EFF 325-1916MG ORAL |
| HIC3 | H3D |
| HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
| GCN | 25515 |
| HICL Sequence Number | 001801 |
| HICL Sequence Number Description | ASPIRIN/SODIUM BICARBONATE/CITRIC ACID |
| Brand/Generic | Brand |
| Proprietary Name | Alka-Seltzer Original |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Active Ingredient Strength | 1000; 325; 1916 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE |
| Labeler Name | Bayer HealthCare LLC. |
| Pharmaceutical Class | Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Ac |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00280-4000-02 (00280400002)
| NDC Package Code | 0280-4000-02 |
|---|---|
| Billing NDC | 00280400002 |
| Package | 24 POUCH in 1 CARTON (0280-4000-02) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| Marketing Start Date | 2012-10-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |